| Fund ID | 805-9419227203 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 98% |
| Fund | Type | Gross assets |
|---|---|---|
| Blackstone Life Sciences V L.P. | Private Equity | $6.13B |
| Blackstone Life Sciences VI L.P. | Private Equity | $1.4B |
| Blackstone Life Sciences Yield Nt L.P. | Other Private | $806.7M |
Blackstone Life Sciences VI (lux) Scsp reports $204 million in gross assets, among the top 30% of private funds by size.
The stated minimum investment is $10 million.
Blackstone Life Sciences VI (lux) Scsp is managed by Blackstone Life Sciences Advisors L.L.C.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.